M. Toivonen

Interactions of y+LAT1 and 4F2hc in the y+l amino acid transporter complex: consequences of lysinuric protein intolerance-causing mutations.

O. Simell, J. Mykkänen, K. Heiskanen, 2013, General physiology and biophysics.

OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area

H. Suominen, U. Kujala, T. Takala, 2013, Experimental Gerontology.

Expression of normal and mutant GFP-tagged y(+)L amino acid transporter-1 in mammalian cells.

O. Simell, K. Huoponen, M. Savontaus, 2002, Biochemical and biophysical research communications.

Multi-site Evaluation and Validation of a Sensitive Diagnostic and Screening System for Spinal Muscular Atrophy that Reports SMN1 and SMN2 Copy Number, along with Disease Modifier and Gene Duplication Variants.

Jessica L. Larson, J. Schleutker, K. Abbott, 2021, The Journal of molecular diagnostics : JMD.

Fluorescence-based imaging of cellular defect in lysinuric protein intolerance (LPI)

M. Toivonen, 2013 .

Heterodimerization of y(+)LAT-1 and 4F2hc visualized by acceptor photobleaching FRET microscopy.

O. Simell, K. Huoponen, J. Mykkänen, 2007, Biochimica et biophysica acta.

Promoter analysis of the human SLC7A7 gene encoding y+L amino acid transporter-1 (y+LAT-1).

O. Simell, K. Huoponen, M. Savontaus, 2003, Biochemical and biophysical research communications.

Severe ulcerative proctitis, pyoderma gangrenosum, hidradenitis suppurativa and fever in a patient with a rare variant of the PSTPIP1 gene

L. Talve, K. Salminen, H. Kujari, 2021, Clinical and experimental dermatology.